Skip to main content

Table 5 Modification effects of estrogen exposure on the associations between reproductive tract infections and prognosis

From: Interaction of reproductive tract infections with estrogen exposure on breast cancer risk and prognosis

Estrogen exposure

Reproductive tract infections

Total

OS

PFS

Events (%)

HR (95%CI)a

Events (%)

HR (95%CI)a

Number of menstrual cycles

  ≤ 327

No

873

86 (7.7)

1.00 (reference)

177 (16.0)

1.00 (reference)

Yes

232

17 (7.3)

0.74 (0.38,1.43)

45 (19.3)

1.10 (0.73,1.64)

  > 327

No

1886

149 (7.9)

1.00 (reference)

267 (14.1)

1.00 (reference)

Yes

322

15 (4.6)

0.56 (0.24,1.28)

37 (11.4)

0.52 (0.34,0.79)

P for interaction

 

0.286

0.015

Reproductive time -Duration of parity—Breastfeeding duration (years)

  ≤ 25

No

886

67 (7.5)

1.00 (reference)

131 (14.7)

1.00 (reference)

Yes

261

21 (8.0)

0.82 (0.44,1.53)

53 (20.3)

1.13 (0.82,1.76)

  > 25

No

1966

158 (8.0)

1.00 (reference)

280 (14.2)

1.00 (reference)

Yes

341

12 (3.5)

0.42 (0.22,0.80)

38 (11.1)

0.56 (0.38,0.84)

P for interaction

 

0.137

0.013

Reproductive time—Duration of all pregnancies—Breastfeeding duration (years)

  ≤ 25

No

846

67 (7.9)

1.00 (reference)

125 (14.7)

1.00 (reference)

Yes

254

21 (8.2)

0.79 (0.43,1.47)

54 (21.2)

1.21 (0.83,1.76)

  > 25

No

1871

151 (8.0)

1.00 (reference)

272 (14.5)

1.00 (reference)

Yes

324

12 (3.7)

0.43 (0.22,0.82)

37 (11.4)

0.54 (0.36,0.81)

P for interaction

 

0.165

0.005

  1. Bold indicates statistically significant values
  2. a The multivariate COX model, adjusted for age at diagnosis, menopausal, education, marital status, BMI, ER status, HER2 status, family history, clinical stage